Feed ZYBT
ZY

Zhengye Biotechnology Holding Limited

ZYBT · NASDAQ

$1.37 -2.84% (-$0.04)
1M -29.74%
Market Cap ¥434.2M
P/E Ratio -
Div. Yield -
ROE 25.78%
Valuation
32 /100
Expensive
P/S 3.73x
P/B 1.74x
P/FCF 617.70x
Growth
0 /100
Declining
Rev. growth 23.53%
Book val. growth 5.55%
EPS growth N/A
Profitability
9 /100
Weak
Gross margin 20.51%
Net margin 59.97%
Op. margin 58.66%
Quality
3 /100
Poor
ROIC 20.63%
ROE 25.78%
ROA 15.99%
Debt
57 /100
Moderate
Debt/Equity 0.30x
Current ratio 1.14x
Int. coverage -20.14x
Stability
55 /100
Moderate
Beta -2.53x
Rev. volatility 13.28%
EPS volatility 33.86%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ZYBT
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Songlin Song

Employees

269

Headquarters

Jilin

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.